ClearPores

A new acne treatment from GlaxoSmithKline (NYSE:GSK) now has marketing approval in the United States to tackle pimples and blackheads in acne sufferers. Tazarotene, which will be marketed under the name Fabior Foam, is a topical foam developed to treat acne vulgaris. Fabior now has U.S. Food and Drug Administration approval to treat the moderate-to-severe acne [...]  

PHOENIX, April 16, 2012 /PRNewswire/ -- the forecast calls for clear skin and sunny days with philosophy's new clear days ahead acne treatment collection. this advanced acne system is designed to deliver ...